Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11195)
All Articles published online
|
Publishing Process of This Article
|
Sep 15, 2016 (publication date) through Nov 9, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ohhara Y, Fukuda N, Takeuchi S, Honma R, Shimizu Y, Kinoshita I, Dosaka-Akita H. Role of targeted therapy in metastatic colorectal cancer. World J Gastrointest Oncol 2016; 8(9): 642-655 [PMID: 27672422 DOI: 10.4251/wjgo.v8.i9.642] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v8/i9/642.htm |
| Number | Citing Articles |
| 1 |
Elena De Mattia, Alessia Bignucolo, Giuseppe Toffoli, Erika Cecchin. Genetic Markers of the Host to Predict the Efficacy of Colorectal Cancer Targeted Therapy. Current Medicinal Chemistry 2020; 27(25): 4249 doi: 10.2174/0929867326666190712151417
|
| 2 |
Omayma Mazouji, Abdelhak Ouhajjou, Roberto Incitti, Hicham Mansour. Updates on Clinical Use of Liquid Biopsy in Colorectal Cancer Screening, Diagnosis, Follow-Up, and Treatment Guidance. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.660924
|
| 3 |
Yun‐Jie Shi, Quan‐Quan Zhao, Xiao‐Shuang Liu, Su‐He Dong, Ji‐Fu E, Xu Li, Cong Liu, Hao Wang. Toll‐like receptor 4 regulates spontaneous intestinal tumorigenesis by up‐regulating IL‐6 and GM‐CSF. Journal of Cellular and Molecular Medicine 2020; 24(1): 385 doi: 10.1111/jcmm.14742
|
| 4 |
Camille Boulagnon-Rombi, Christophe Schneider, Chloé Leandri, Albin Jeanne, Virginie Grybek, Aude Marchal Bressenot, Coralie Barbe, Benjamin Marquet, Saviz Nasri, Christelle Coquelet, Caroline Fichel, Nicole Bouland, Arnaud Bonnomet, Reza Kianmanesh, Anne-Sophie Lebre, Olivier Bouché, Marie-Danièle Diebold, Georges Bellon, Stéphane Dedieu. LRP1 expression in colon cancer predicts clinical outcome. Oncotarget 2018; 9(10): 8849 doi: 10.18632/oncotarget.24225
|
| 5 |
Roberto Dinami, Manuela Porru, Carla Azzurra Amoreo, Isabella Sperduti, Marcella Mottolese, Simonetta Buglioni, Daniele Marinelli, Marcello Maugeri-Saccà, Andrea Sacconi, Giovanni Blandino, Carlo Leonetti, Giuliana Di Rocco, Alessandra Verdina, Francesca Spinella, Francesco Fiorentino, Gennaro Ciliberto, Annamaria Biroccio, Pasquale Zizza. TRF2 and VEGF-A: an unknown relationship with prognostic impact on survival of colorectal cancer patients. Journal of Experimental & Clinical Cancer Research 2020; 39(1) doi: 10.1186/s13046-020-01612-z
|
| 6 |
George Papaxoinis, Vassiliki Kotoula, Eleni Giannoulatou, Georgia-Angeliki Koliou, Vasilios Karavasilis, Sotirios Lakis, Andreas Koureas, Mattheos Bobos, Elpida Chalaralambous, Emily Daskalaki, Kyriakos Chatzopoulos, George Tsironis, Elisavet Pazarli, Sofia Chrisafi, Epaminontas Samantas, Ioannis G. Kaklamanos, Ioannis Varthalitis, Athina Konstantara, Konstantinos N. Syrigos, George Pentheroudakis, Dimitrios Pectasides, George Fountzilas. Phase II study of panitumumab combined with capecitabine and oxaliplatin as first-line treatment in metastatic colorectal cancer patients: clinical results including extended tumor genotyping. Medical Oncology 2018; 35(7) doi: 10.1007/s12032-018-1160-1
|
| 7 |
Bingjun Bai, Lina Shan, Binbin Xie, Xuefeng Huang, Weifang Mao, Xiaowei Wang, Da Wang, Hongbo Zhu. Mutations in KRAS codon 12 predict poor survival in Chinese patients with metastatic colorectal cancer. Oncology Letters 2017; doi: 10.3892/ol.2017.7709
|
| 8 |
Xiaofang Qiao, Guangmei Zhang, Yajie Xiao, Xiaoli Cui, Zhikun Zhao, Dongfang Wu, Xuefei Liu, Jinfang Zheng. Exploring the Interplay between Metabolism and Tumor Microenvironment Based on Four Major Metabolism Pathways in Colon Adenocarcinoma. Journal of Oncology 2022; 2022: 1 doi: 10.1155/2022/2159794
|
| 9 |
Zhikun Liang, Xiaoyan Li. Identification of ANXA1 as a potential prognostic biomarker and correlating with immune infiltrates in colorectal cancer. Autoimmunity 2021; 54(2): 76 doi: 10.1080/08916934.2021.1887148
|
| 10 |
Peng Wang, Yongmin Sun, Yang Yang, Yanzhao Chen, Hui Liu. Circ_0067835 Knockdown Enhances the Radiosensitivity of Colorectal Cancer by miR-296-5p/IGF1R Axis. OncoTargets and Therapy 2021; : 491 doi: 10.2147/OTT.S281011
|
| 11 |
Marlon Osorio, Estefanía Martinez, Tonny Naranjo, Cristina Castro. Recent Advances in Polymer Nanomaterials for Drug Delivery of Adjuvants in Colorectal Cancer Treatment: A Scientific-Technological Analysis and Review. Molecules 2020; 25(10): 2270 doi: 10.3390/molecules25102270
|
| 12 |
Verena Haselmann, Parviz Ahmad-Nejad, Wolf J. Geilenkeuser, Angelika Duda, Merle Gabor, Romy Eichner, Simon Patton, Michael Neumaier. Results of the first external quality assessment scheme (EQA) for isolation and analysis of circulating tumour DNA (ctDNA). Clinical Chemistry and Laboratory Medicine (CCLM) 2018; 56(2): 220 doi: 10.1515/cclm-2017-0283
|
| 13 |
Morena Fasano, Alessio Fabozzi, Guido Giordano, Filippo Venturini, Gaetano Aurilio, Flavia Cantile, Teresa Fabozzi, Vincenzo Ricci, Giuseppe Santabarbara, Floriana Morgillo, Fortunato Ciardiello, Ferdinando De Vita. Complete response to capecitabine in a frail, elderly patient with metastatic colorectal cancer: A case report. Oncology Letters 2017; 13(2): 979 doi: 10.3892/ol.2016.5523
|
| 14 |
Aurelie Maisonial-Besset, Tiffany Witkowski, Isabelle Navarro-Teulon, Odile Berthier-Vergnes, Giovanna Fois, Yingying Zhu, Sophie Besse, Olivia Bawa, Arnaud Briat, Mercedes Quintana, Alexandre Pichard, Mathilde Bonnet, Eric Rubinstein, Jean-Pierre Pouget, Paule Opolon, Lydia Maigne, Elisabeth Miot-Noirault, Jean-Michel Chezal, Claude Boucheix, Françoise Degoul. Tetraspanin 8 (TSPAN 8) as a potential target for radio-immunotherapy of colorectal cancer. Oncotarget 2017; 8(13): 22034 doi: 10.18632/oncotarget.15787
|
| 15 |
Rei Mizuno, Kenji Kawada, Yoshiro Itatani, Ryotaro Ogawa, Yoshiyuki Kiyasu, Yoshiharu Sakai. The Role of Tumor-Associated Neutrophils in Colorectal Cancer. International Journal of Molecular Sciences 2019; 20(3): 529 doi: 10.3390/ijms20030529
|
| 16 |
Xiao-Dong Chu, Hui Bao, Yu-Jian Lin, Ruo-Xi Chen, Yi-Ran Zhang, Ting Huang, Jia-Shuai He, Shu-Chen Huangfu, Yun-Long Pan, Hui Ding. Endostatin induces normalization of blood vessels in colorectal cancer and promotes infiltration of CD8+ T cells to improve anti-PD-L1 immunotherapy. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.965492
|
| 17 |
K. Jakubowska, M. Koda, W. Kisielewski, K. Lomperta, M. Grudzińska, W. Famulski. Role of tumour- associated neutrophils in tissue material and systemic neutrophil inflammation in colorectal cancer patients. Progress in Health Sciences 2021; 11(2): 85 doi: 10.5604/01.3001.0015.6402
|
| 18 |
Sepehr Khorasani, Arun Nagarajan, Timothy Nguyen, Sami A. Chadi. Fundamentals of Anorectal Surgery. 2019; : 445 doi: 10.1007/978-3-319-65966-4_24
|
| 19 |
Tuoyu Zhou, Jingyuan Wu, Haibo Tang, Dali Liu, Byong-Hun Jeon, Weilin Jin, Yiqing Wang, Yuanzhang Zheng, Aman Khan, Huawen Han, Xiangkai Li. Enhancing tumor-specific recognition of programmable synthetic bacterial consortium for precision therapy of colorectal cancer. npj Biofilms and Microbiomes 2024; 10(1) doi: 10.1038/s41522-024-00479-8
|
| 20 |
Omar Al-Obeed, Adila Salih El-Obeid, Sabine Matou-Nasri, Mansoor-Ali Vaali-Mohammed, Yazeid AlHaidan, Mohammed Elwatidy, Hamad Al Dosary, Zeyad Alehaideb, Khayal Alkhayal, Adil Haseeb, James McKerrow, Rehan Ahmad, Maha-Hamadien Abdulla. Herbal melanin inhibits colorectal cancer cell proliferation by altering redox balance, inducing apoptosis, and modulating MAPK signaling. Cancer Cell International 2020; 20(1) doi: 10.1186/s12935-020-01206-x
|
| 21 |
Maria Michelli, Alexandros Zougros, Ilenia Chatziandreou, Nikolaos V. Michalopoulos, Andreas C. Lazaris, Angelica A. Saetta. Concurrent Wnt pathway component expression in breast and colorectal cancer. Pathology - Research and Practice 2020; 216(7): 153005 doi: 10.1016/j.prp.2020.153005
|
| 22 |
Asiyeh Jebelli, Behzad Baradaran, Jafar Mosafer, Amir Baghbanzadeh, Ahad Mokhtarzadeh, Lobat Tayebi. Recent developments in targeting genes and pathways by RNAi‐based approaches in colorectal cancer. Medicinal Research Reviews 2021; 41(1): 395 doi: 10.1002/med.21735
|
| 23 |
Mohamed Adil, Anandraj K. Vaithy.k, Ashok Kumar Pandurangan, Mohammad Waseem, Neesar Ahmed. Diagnostic and Treatment Methods for Ulcerative Colitis and Colitis-Associated Cancer. Advances in Medical Diagnosis, Treatment, and Care 2021; : 24 doi: 10.4018/978-1-7998-3580-6.ch002
|
| 24 |
Shamar Young, Donna D’Souza, Siobhan Flanagan, Jafar Golzarian. Review of the Clinical Evidence for the Use of DEBIRI in the Treatment of Colorectal Metastatic Disease. CardioVascular and Interventional Radiology 2017; 40(4): 496 doi: 10.1007/s00270-016-1537-5
|
| 25 |
Muttiah Barathan, Ahmad Khusairy Zulpa, Sook Luan Ng, Yogeswaran Lokanathan, Min Hwei Ng, Jia Xian Law. Innovative Strategies to Combat 5-Fluorouracil Resistance in Colorectal Cancer: The Role of Phytochemicals and Extracellular Vesicles. International Journal of Molecular Sciences 2024; 25(13): 7470 doi: 10.3390/ijms25137470
|
| 26 |
C. L. Chiang, H. C. Choi, K. O. Lam, B. Y. Chan, S. F. Lee, S. Y. Yeung, K. S. Lau, S. Y. Chan, T. S. Choy, K. K. Yuen. Real‐world treatment patterns and outcomes in refractory metastatic colorectal cancer. Asia-Pacific Journal of Clinical Oncology 2019; 15(S2): 5 doi: 10.1111/ajco.13114
|
| 27 |
Alessia Bignucolo, Elena De Mattia, Erika Cecchin, Rossana Roncato, Giuseppe Toffoli. Pharmacogenomics of Targeted Agents for Personalization of Colorectal Cancer Treatment. International Journal of Molecular Sciences 2017; 18(7): 1522 doi: 10.3390/ijms18071522
|
| 28 |
Meysam Ganjibakhsh, Roshanak Monshizadeh, Ahmad Nasimian, Pouyan Aminishakib, Parvaneh Farzaneh, Sahar Tavakoli Shiraji, Ata Gharajei, Sedigheh Rahrotaban, Fereshteh Baghaei, Neda Sadat Gohari. Anti‐angiogenic efficacy of aflibercept and bevacizumab in primary oral squamous cell carcinoma cells. Journal of Oral Pathology & Medicine 2018; 47(6): 575 doi: 10.1111/jop.12717
|
| 29 |
Sang-A Kim, Ji-Won Kim, Koung Jin Suh, Won Chang, Jin Won Kim, Heung-Kwon Oh, Jai Young Cho, Duck-Woo Kim, Sukki Cho, Jee Hyun Kim, Kwhanmien Kim, Sung-Bum Kang, Sanghoon Jheon, Keun-Wook Lee. Conversion surgery after cetuximab or bevacizumab plus FOLFIRI chemotherapy in colorectal cancer patients with liver- and/or lung-limited metastases. Journal of Cancer Research and Clinical Oncology 2020; 146(9): 2399 doi: 10.1007/s00432-020-03233-7
|
| 30 |
Mingli Yang, Timothy J Yeatman. Molecular stratification of colorectal cancer populations and its use in directing precision medicine. Expert Review of Precision Medicine and Drug Development 2017; 2(4): 205 doi: 10.1080/23808993.2017.1362316
|
| 31 |
E. Aranda, E. Polo, C. Camps, A. Carrato, E. Díaz-Rubio, V. Guillem, R. López, A. Antón. Treatment patterns for metastatic colorectal cancer in Spain. Clinical and Translational Oncology 2020; 22(9): 1455 doi: 10.1007/s12094-019-02279-5
|
| 32 |
Mingyue Li, Grace Gar-Lee Yue, Lianxiang Luo, Stephen Kwok-Wing Tsui, Kwok-Pui Fung, Simon Siu-Man Ng, Clara Bik-San Lau. Turmeric Is Therapeutic in Vivo on Patient-Derived Colorectal Cancer Xenografts: Inhibition of Growth, Metastasis, and Tumor Recurrence. Frontiers in Oncology 2021; 10 doi: 10.3389/fonc.2020.574827
|
| 33 |
Sepideh Ghani, Samira Bahrami, Behnam Rafiee, Shirin Eyvazi, Fatemeh Yarian, Shahrzad Ahangarzadeh, Saeed Khalili, Kiana Shahzamani, Moslem Jafarisani, Mojgan Bandehpour, Bahram Kazemi. Recent developments in antibody derivatives against colorectal cancer; A review. Life Sciences 2021; 265: 118791 doi: 10.1016/j.lfs.2020.118791
|
| 34 |
Yujia Xia, Jiayi He, Hongji Zhang, Han Wang, George Tetz, Casey A. Maguire, Yu Wang, Amblessed Onuma, Dmitry Genkin, Victor Tetz, Alexey Stepanov, Stanislav Terekhov, Valeria Ukrainskaya, Hai Huang, Allan Tsung. AAV‐mediated gene transfer of DNase I in the liver of mice with colorectal cancer reduces liver metastasis and restores local innate and adaptive immune response. Molecular Oncology 2020; 14(11): 2920 doi: 10.1002/1878-0261.12787
|
| 35 |
Xin Yi Wong, Andrew Qi Jun Lim, Qianyu Shen, John Whay Kuang Chia, Min Hoe Chew, Wah Siew Tan, Hwee-Lin Wee. Patient preferences and predicted relative uptake for targeted therapies in metastatic colorectal cancer: a discrete choice experiment. Current Medical Research and Opinion 2020; 36(10): 1677 doi: 10.1080/03007995.2020.1790348
|
| 36 |
Moein Piroozkhah, Ali Aghajani, Pooya Jalali, Arvin Shahmoradi, Mobin Piroozkhah, Younes Tadlili, Zahra Salehi. Guanylate cyclase-C Signaling Axis as a theragnostic target in colorectal cancer: a systematic review of literature. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1277265
|
| 37 |
Aaron T. Ciner, Keaton Jones, Ruth J. Muschel, Pnina Brodt. The unique immune microenvironment of liver metastases: Challenges and opportunities. Seminars in Cancer Biology 2021; 71: 143 doi: 10.1016/j.semcancer.2020.06.003
|
| 38 |
Ryu Kanzaki, Osamu Suzuki, Takashi Kanou, Naoko Ose, Soichiro Funaki, Yasushi Shintani, Masato Minami, Keisuke Tamari, Keisuke Otani, Yuji Seo, Fumiaki Isohashi, Kazuhiko Ogawa, Meinoshin Okumura. The short-term outcomes of pulmonary metastasectomy or stereotactic body radiation therapy for pulmonary metastasis from epithelial tumors. Journal of Cardiothoracic Surgery 2020; 15(1) doi: 10.1186/s13019-020-1079-4
|
| 39 |
Houxi Xu, Yuzhu Ma, Jinzhi Zhang, Jialin Gu, Xinyue Jing, Shengfeng Lu, Shuping Fu, Jiege Huo. Identification and Verification of Core Genes in Colorectal Cancer. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/8082697
|
| 40 |
Biswajit Mukherjee, Samrat Chakraborty, Iman Ehsan, Apala Chakraborty, Leena Kumari, Alankar Mukherjee, Shounak Sarkhel. Nanoformulations in Human Health. 2020; : 111 doi: 10.1007/978-3-030-41858-8_6
|
| 41 |
Evgeniya A. Sokolova, Vladimir A. Vodeneev, Sergey M. Deyev, Irina V. Balalaeva. 3D in vitro models of tumors expressing EGFR family receptors: a potent tool for studying receptor biology and targeted drug development. Drug Discovery Today 2019; 24(1): 99 doi: 10.1016/j.drudis.2018.09.003
|
| 42 |
Alexey A. Tryakin, Mikhail Yu. Fedyanin, Fedor V. Moiseenko, Oleg V. Mironov, Daniil L. Stroyakovskiy, Nikolai Iu. Sokolov, Svetlana A. Orlova, Evgenii O. Mantsyrev, Alexander V. Sultanbaev, Antonina A. Teterich, Kseniia G. Babina, Denis Yu. Yukalchuk, Stanislav M. Borzyanitsa, Alina Z. Isyangulova, Aleksandra F. Saidullaeva, Yuliia A. Chernova, Elvira A. Bobrova, Natalia V. Fadeeva, Dmitrii Yu. Chobanu. Multicenter prospective observational post-approval study of safety and efficacy of bevacizumab (Avegra®, BIOCAD) in patients with metastatic colorectal cancer in real world practice: APOLLON-11 and SOYUZ-APOLLON. Journal of Modern Oncology 2021; 23(4): 695 doi: 10.26442/18151434.2021.4.201307
|
| 43 |
Junji Ueda, Hiroshi Yoshida, Hiroshi Makino, Hiroshi Maruyama, Tadashi Yokoyama, Atsushi Hirakata, Hideyuki Takata, Natsuki Seki, Yuta Kikuchi, Eiji Uchida. A case of sigmoid colon adenocarcinoma diagnosed as facial cutaneous metastasis for survival after operation for 37 months. Clinical Journal of Gastroenterology 2017; 10(5): 420 doi: 10.1007/s12328-017-0767-7
|
| 44 |
Satomi Kawamoto. Therapy Response Imaging in Oncology. Medical Radiology 2020; : 99 doi: 10.1007/978-3-030-31171-1_7
|
| 45 |
M. V. Zabelin, S. S. Gordeev, S. O. Kochkina, A. A. Kostin, A. A. Fedenko, L. O. Petrov, E. V. Gameeva. New therapeutic agents for metastatic colorectal cancer: literature review. Colorectal Oncology 2018; 8(4): 34 doi: 10.17650/2220-3478-2018-8-4-34-46
|
| 46 |
Meng‑Meng Wei, Shuang‑Shuang Wang, Jia‑Lu Zheng, Jin‑Jun Chen, Xia Yan, Hong‑Mei An, Bing Hu. Herbal compound Teng‑Long‑Bu‑Zhong‑Tang inhibits metastasis in human RKO colon carcinoma. Oncology Letters 2017; doi: 10.3892/ol.2017.7206
|
| 47 |
Daniel-Clement Osei-Bordom, Sivesh Kamarajah, Niki Christou. Colorectal Cancer, Liver Metastases and Biotherapies. Biomedicines 2021; 9(8): 894 doi: 10.3390/biomedicines9080894
|
| 48 |
Wonseok Shin, Jeongseok Yun, Kyudong Han, Dong-Guk Park. Comparison of genetic variation between primary colorectal cancer and metastatic peritoneal cancer. Genes & Genomics 2023; 45(8): 989 doi: 10.1007/s13258-023-01408-3
|
| 49 |
Tania Fleitas-Kanonnikoff, Carolina Martinez‐Ciarpaglini, Josefina Ayala, Cinthia Gauna, Rita Denis, Ita Yoffe, Silvia Sforza, María Teresa Martínez, Alicia Pomata, Maider Ibarrola‐Villava, Sipan Arevshatyan, Verónica Burriel, Diego Boscá, Oscar Pastor, Ana Ferrer‐Martinez, Francisca Carrasco, Cristina Mongort, Samuel Navarro, Gloria Ribas, Andres Cervantes. Molecular profile in Paraguayan colorectal cancer patients, towards to a precision medicine strategy. Cancer Medicine 2019; 8(6): 3120 doi: 10.1002/cam4.2191
|
| 50 |
Kumaravel Mohankumar, Gus Wright, Subhashree Kumaravel, Rupesh Shrestha, Lei Zhang, Maen Abdelrahim, Robert S. Chapkin, Stephen Safe. Bis-indole-derived NR4A1 antagonists inhibit colon tumor and splenic growth and T-cell exhaustion. Cancer Immunology, Immunotherapy 2023; 72(12): 3985 doi: 10.1007/s00262-023-03530-3
|
| 51 |
Mohammad Amin Tabatabaiefar, Abbas Moridnia. Cancer Genetics and Psychotherapy. 2017; : 589 doi: 10.1007/978-3-319-64550-6_12
|
| 52 |
Zheying Zhang, Cheng Fang, Yongxia Wang, Jinghang Zhang, Jian Yu, Yongxi Zhang, Xianwei Wang, Jiateng Zhong. COL1A1: A potential therapeutic target for colorectal cancer expressing wild-type or mutant KRAS. International Journal of Oncology 2018; doi: 10.3892/ijo.2018.4536
|
| 53 |
Johann Ebadfardzadeh, Mandana Kazemi, Ali Aghazadeh, Monireh Rezaei, Milad Shirvaliloo, Roghayeh Sheervalilou. Employing bioinformatics analysis to identify hub genes and microRNAs involved in colorectal cancer. Medical Oncology 2021; 38(9) doi: 10.1007/s12032-021-01543-5
|
| 54 |
Pietro Andrei, Paolo Battuello, Gaia Grasso, Emanuele Rovera, Nicolò Tesio, Alberto Bardelli. Integrated approaches for precision oncology in colorectal cancer: The more you know, the better. Seminars in Cancer Biology 2022; 84: 199 doi: 10.1016/j.semcancer.2021.04.007
|
| 55 |
Md Abu Horaira, Md. Ariful Islam, Md. Kaderi Kibria, Md. Jahangir Alam, Syed Rashel Kabir, Md. Nurul Haque Mollah. Bioinformatics screening of colorectal-cancer causing molecular signatures through gene expression profiles to discover therapeutic targets and candidate agents. BMC Medical Genomics 2023; 16(1) doi: 10.1186/s12920-023-01488-w
|
| 56 |
Jeffrey S. Ross, Marwan Fakih, Siraj M. Ali, Julia A. Elvin, Alexa B. Schrock, James Suh, Jo‐Anne Vergilio, Shakti Ramkissoon, Eric Severson, Sugganth Daniel, David Fabrizio, Garrett Frampton, James Sun, Vincent A. Miller, Philip J. Stephens, Laurie M. Gay. Targeting HER2 in colorectal cancer: The landscape of amplification and short variant mutations in ERBB2 and ERBB3. Cancer 2018; 124(7): 1358 doi: 10.1002/cncr.31125
|
| 57 |
María Antonia Lizarbe, Jorge Calle-Espinosa, Eva Fernández-Lizarbe, Sara Fernández-Lizarbe, Miguel Ángel Robles, Nieves Olmo, Javier Turnay. Colorectal Cancer: From the Genetic Model to Posttranscriptional Regulation by Noncoding RNAs. BioMed Research International 2017; 2017: 1 doi: 10.1155/2017/7354260
|
| 58 |
Timothy J. Yeatman, Mingli Yang, Domenico Coppola. Whole Genome Sequencing Analysis of a Stage IV Colon Cancer Patient with a 10-Year Disease-Free Survival following Systemic Chemotherapy/Bevacizumab. Case Reports in Gastroenterology 2018; 12(3): 729 doi: 10.1159/000494751
|
| 59 |
Hang Li, Dan Li, Ning Meng. Effects of RUNX3 mediated Notch signaling pathway on biological characteristics of colorectal cancer cells. International Journal of Oncology 2017; 50(6): 2059 doi: 10.3892/ijo.2017.3988
|
| 60 |
Youenn Drouet, Isabelle Treilleux, Alain Viari, Sophie Léon, Mojgan Devouassoux-Shisheboran, Nicolas Voirin, Christelle de la Fouchardière, Brigitte Manship, Alain Puisieux, Christine Lasset, Caroline Moyret-Lalle. Integrated analysis highlights APC11 protein expression as a likely new independent predictive marker for colorectal cancer. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-25631-1
|
| 61 |
Yunfei Dong, Huiyan Bao, Zhengyu Fang, Zhi Chen. Mechanism of cinobufacin anti-metastatic colorectal cancer based on integrated mining of proteomics and bioinformatics. Materials Express 2023; 13(7): 1226 doi: 10.1166/mex.2023.2452
|
| 62 |
Nico Jacobi, Rita Seeboeck, Elisabeth Hofmann, Andreas Eger. ErbB Family Signalling: A Paradigm for Oncogene Addiction and Personalized Oncology. Cancers 2017; 9(4): 33 doi: 10.3390/cancers9040033
|
| 63 |
Ozkan Kanat, Hulya Ertas. Existing anti-angiogenic therapeutic strategies for patients with metastatic colorectal cancer progressing following first-line bevacizumab-based therapy. World Journal of Clinical Oncology 2019; 10(2): 52-61 doi: 10.5306/wjco.v10.i2.52
|
| 64 |
Thierry Andre, Mayur Amonkar, Josephine M Norquist, Kai-Keen Shiu, Tae Won Kim, Benny Vittrup Jensen, Lars Henrik Jensen, Cornelis J A Punt, Denis Smith, Rocio Garcia-Carbonero, Isabel Sevilla, Christelle De La Fouchardiere, Fernando Rivera, Elena Elez, Luis A Diaz, Takayuki Yoshino, Eric Van Cutsem, Ping Yang, Mohammed Farooqui, Dung T Le. Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial. The Lancet Oncology 2021; 22(5): 665 doi: 10.1016/S1470-2045(21)00064-4
|
| 65 |
Quitterie Fontanges, Ricardo De Mendonca, Isabelle Salmon, Marie Le Mercier, Nicky D’Haene. Clinical Application of Targeted Next Generation Sequencing for Colorectal Cancers. International Journal of Molecular Sciences 2016; 17(12): 2117 doi: 10.3390/ijms17122117
|
| 66 |
Hui-Ying Wu, Bin Yang, Dong-Hua Geng. Clinical significance of expression of fibrous sheath interacting protein 1 in colon cancer. World Journal of Gastrointestinal Oncology 2020; 12(6): 677-686 doi: 10.4251/wjgo.v12.i6.677
|
| 67 |
The Effective Role of Targeted Therapy in Advanced Colorectal Cancer. Al Mustansiriyah Journal of Pharmaceutical Sciences 2022; 22(2): 20 doi: 10.32947/ajps.v22i2.835
|
| 68 |
Cheng-Ta Lai, Chih-Wen Chi, Shu-Hua Wu, Hui-Ru Shieh, Jiin-Cherng Yen, Yu-Jen Chen. Midostaurin Modulates Tumor Microenvironment and Enhances Efficacy of Anti-PD-1 against Colon Cancer. Cancers 2022; 14(19): 4847 doi: 10.3390/cancers14194847
|
| 69 |
Jingfeng Zhang, Sifeng Hu, Yansen Li. KRT18 is correlated with the malignant status and acts as an oncogene in colorectal cancer. Bioscience Reports 2019; 39(8) doi: 10.1042/BSR20190884
|
| 70 |
D. A. Andreev, A. A. Zav'yalov, K. A. Kokushkin, M. V. Davydovskaya. The application of the modern target medications for the treatment of metastatic colorectal cancer. Dokazatel'naya gastroenterologiya 2018; 7(2): 21 doi: 10.17116/dokgastro20187221
|
| 71 |
Eun-Ji Lim, Jae-Hyeok Kang, Yeon-Ju Kim, Seungmo Kim, Su-Jae Lee. ICAM-1 promotes cancer progression by regulating SRC activity as an adapter protein in colorectal cancer. Cell Death & Disease 2022; 13(4) doi: 10.1038/s41419-022-04862-1
|
| 72 |
Nkune W. Nkune, Cherie A. Kruger, Heidi Abrahamse. Possible Enhancement of Photodynamic Therapy (PDT) Colorectal Cancer Treatment when Combined with Cannabidiol. Anti-Cancer Agents in Medicinal Chemistry 2021; 21(2): 137 doi: 10.2174/1871520620666200415102321
|
| 73 |
Ahmed El Kaffas, Assaf Hoogi, Jianhua Zhou, Isabelle Durot, Huaijun Wang, Jarrett Rosenberg, Albert Tseng, Hersh Sagreiya, Alireza Akhbardeh, Daniel L. Rubin, Aya Kamaya, Dimitre Hristov, Jürgen K. Willmann. Spatial Characterization of Tumor Perfusion Properties from 3D DCE-US Perfusion Maps are Early Predictors of Cancer Treatment Response. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-63810-1
|